Xiangdan injection should be used in medical institutions with rescue conditions
-
Last Update: 2012-04-24
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Zhang Dongfeng, a reporter, learned from the State Food and Drug Administration on April 12 that in order to control the use risk of Xiangdan injection and protect the drug safety of patients, the bureau had recently revised the instructions of Xiangdan injection The revised manual added warning words, pointing out that the adverse reactions of the drug include anaphylactic shock, which should be used in the medical institutions with rescue conditions In case of anaphylactic reaction or other serious adverse reactions, the drug should be stopped immediately and treated in time According to the notice of the State Food and drug administration, the food and Drug Administration of each province (district or city) shall urge the drug manufacturing enterprises within its jurisdiction to revise the instructions and labels as soon as possible, put them on record in accordance with the relevant regulations, notify the relevant medical institutions, drug trading enterprises and other units in a timely manner, and replace the ex factory instructions as soon as possible.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
